CEA-targeted CAR-T cells Clinical Trials

4 actively recruiting trials

▼ -1 trial since August 2026

Pipeline

Phase 1: 4

Top Sponsors

Chongqing Precision Biotech Co., Ltd3
Second Affiliated Hospital, Zhejiang University, School of Medicine1

Indications

Cancer4
Pancreas Cancer3
Gastric Cancer3
Lung Cancer3
Rectal Cancer2

Other4 trials

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Phase 1

CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases

Phase 1

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

Phase 1

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.